Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3645242
Max Phase: Preclinical
Molecular Formula: C32H41F3N6O2
Molecular Weight: 598.71
Molecule Type: Small molecule
Associated Items:
ID: ALA3645242
Max Phase: Preclinical
Molecular Formula: C32H41F3N6O2
Molecular Weight: 598.71
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1CN(C(=O)N(C[C@@H]2CNC[C@@H]2F)[C@@H](c2nc(-c3cc(F)ccc3F)nn2Cc2ccccc2)C(C)(C)C)C[C@H](C)O1
Standard InChI: InChI=1S/C32H41F3N6O2/c1-20-16-39(17-21(2)43-20)31(42)40(19-23-14-36-15-27(23)35)28(32(3,4)5)30-37-29(25-13-24(33)11-12-26(25)34)38-41(30)18-22-9-7-6-8-10-22/h6-13,20-21,23,27-28,36H,14-19H2,1-5H3/t20-,21+,23-,27-,28-/m0/s1
Standard InChI Key: AWBVBYIKAUDSGH-KHNIKYAWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 598.71 | Molecular Weight (Monoisotopic): 598.3243 | AlogP: 5.45 | #Rotatable Bonds: 7 |
Polar Surface Area: 75.52 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 9.47 | CX LogP: 5.70 | CX LogD: 3.65 |
Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.39 | Np Likeness Score: -1.11 |
1. (2013) Triazole compounds as KSP inhibitors, |
Source(1):